摘要
目的探讨膏摩疗法在乳腺癌患者芳香化酶抑制剂相关骨关节症状治疗中的应用效果。方法选取2024年1月—8月在广东省某三级甲等综合医院乳腺科门诊就诊的80例伴芳香化酶抑制剂相关骨关节症状的乳腺癌患者作为研究对象,按照随机数字表法分为干预组和对照组,每组各40例,对照组患者实施常规护理,干预组患者在对照组基础上遵医嘱实施膏摩疗法,干预时间为4w。比较两组干预前及干预第1、2、4周疼痛情况、膝关节炎指数和乳腺癌患者生命质量。结果干预前,两组疼痛评分、膝关节炎指数评分和乳腺癌患者生命质量得分比较,差异无统计学意义(均P>0.05);重复测量的方差分析显示,两组患者疼痛得分不同时间点时间主效应、组间主效应、交互效应具有统计学意义(均P<0.05);两组患者膝关节炎指数评分和乳腺癌患者生命质量得分不同时间点的时间主效应、交互效应均有统计学意义(均P<0.05),但组间主效应无统计学意义(均P>0.05)。经过4w干预后,干预组患者的膝关节功能评定量表评分和疼痛评分低于对照组,乳腺癌患者生命质量量表总分高于对照组,差异具有统计学意义(均P<0.05)。结论应用膏摩疗法可改善乳腺癌患者芳香化酶抑制剂相关骨关节症状,提高患者的膝关节功能活动,改善乳腺癌患者的生活质量。
Objective To analyse the efficacy of Gao Mo therapy in the treatment of aromatase inhibitor-related osteoarticular symptoms in breast cancer patients.Methods A total of 80 breast cancer patients with aromatase inhibitor-related osteoarticular symptoms were selected from the breast clinic of a Tier-IIIA hospital in Guangdong Province between January and August 2024.The patients were divided into an intervention group and a control group according to the random number table,with 40 patients per group.Patients in the control group received routine nursing care,while the patients in the intervention group received Gao Mo therapy for 4 weeks based on the intervention of the control group.The two groups were compared with in terms of pain level,index of knee osteoarthritis,and quality of life of the patients with breast cancer before intervention and at 1st,2nd and 4th weeks after intervention.Results Before the intervention,the two groups presented no significant differences in scores of pain assessment,knee osteoarthritis index and quality of life(P>0.05).Analysis of variance for repeated measures showed that the main effects of time and group as well as the interaction effect,were statistically significant in scores of pain assessments in both groups(both P<0.05).The main effects of time and the interaction effect were statistically significant in scores of knee osteoarthritis index and quality of life assessments at different time points(both P<0.05),but there was no statistically significant difference in the main effect between groups(both P>0.05).After 4 weeks of intervention,the intervention group demonstrated significantly lower scores in knee function and pain assessments with a significantly higher scores in the total quality of life assessment in comparison with those of the control group(all P<0.05).Conclusion Gao Mo therapy can mitigate the aromatase inhibitor-related osteoarticular symptoms in breast cancer patients,enhance the function of knees,and improve the quality of life of the patients with breast cancer.
作者
何远梅
陈昆
张莉玲
吴晓清
吴玢
詹文英
He Yuanmei;Chen Kun;Zhang Liling;Wu Xiaoqing;Wu Fen(Breast Department,Guangdong Provincial Second Traditional Chinese Medicine Hospital,Guangzhou 510095,Guangdong Province,China)
出处
《现代临床护理》
2025年第4期38-44,共7页
Modern Clinical Nursing
基金
广东省第二中医院科研创新基金项目,项目编号为SEZYY2024A02,SEZYY2023B10。
关键词
膏摩疗法
乳腺癌
芳香化酶抑制剂相关骨关节症状
疼痛
生命质量
随机对照研究
Gao Mo therapy
breast cancer
aromatase inhibitor-related osteoarticular symptoms
pain
quality of life
radomized controlled trial
